deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT02400268

Antibiotic Treatment Duration (7 vs 14 Days) Comparison in Blood Stream Infection Causes by Enterobacteriaceae (SHORTEN)

Phase 4, Randomized, Controlled Multicentric, Open-label Clinical Trial to Prove That the 7 Day Course of Treatment for Enterobacteriaceae Bacteremia is More Efficient and Equally Safe Than 14 Day Scheme

Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Conditions Bloodstream Infection Enterobacteriaceae Infections
Interventions 14 days course of antibiotic treatment 7 days course of antibiotic treatment
Updated 6 times since 2017 Last updated: Mar 9, 2017 Started: Sep 30, 2014 Primary completion: Dec 2, 2016 Completion: Mar 1, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Bloodstream Infection and Enterobacteriaceae Infections, this trial is completed. The trial is conducted by Fundación Pública Andaluza para la gestión de la Investigación en Sevilla and has accumulated 6 data snapshots since 2014. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Jan 2017 – ~Apr 2017 · 3 months · monthly snapshotRecruiting~Apr 2017 – ~Jun 2018 · 14 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Apr 2017 — Jun 2018 [monthly]

    Completed PHASE3

    Status: Recruiting → Completed

▶ Show 1 earlier version

  1. Jan 2017 — Apr 2017 [monthly]

    Recruiting PHASE3

    First recorded

Sep 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Data source: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations